» Articles » PMID: 38347543

Triggers for the Onset and Recurrence of Psoriasis: a Review and Update

Overview
Publisher Biomed Central
Date 2024 Feb 12
PMID 38347543
Authors
Affiliations
Soon will be listed here.
Abstract

Psoriasis is an immune-mediated inflammatory skin disease, involving a complex interplay between genetic and environmental factors. Previous studies have demonstrated that genetic factors play a major role in the pathogenesis of psoriasis. However, non-genetic factors are also necessary to trigger the onset and recurrence of psoriasis in genetically predisposed individuals, which include infections, microbiota dysbiosis of the skin and gut, dysregulated lipid metabolism, dysregulated sex hormones, and mental illness. Psoriasis can also be induced by other environmental triggers, such as skin trauma, unhealthy lifestyles, and medications. Understanding how these triggers play a role in the onset and recurrence of psoriasis provides insights into psoriasis pathogenesis, as well as better clinical administration. In this review, we summarize the triggers for the onset and recurrence of psoriasis and update the current evidence on the underlying mechanism of how these factors elicit the disease. Video Abstract.

Citing Articles

Influence of rs2280883 and rs3761548 Variants on IL-10 and TGF-β1 Serum Levels and Plaque Psoriasis Risk in the Mexican Population.

Hernandez-Bello J, Preciado-Aguiar M, Munoz-Valle J, Banos-Hernandez C, Garcia-Arellano S, Alvarado-Navarro A Int J Mol Sci. 2025; 26(5).

PMID: 40076417 PMC: 11898888. DOI: 10.3390/ijms26051789.


Psoriasis Treatments: Emerging Roles and Future Prospects of MicroRNAs.

Teo L, Juantuah-Kusi N, Subramanian G, Sampath P Noncoding RNA. 2025; 11(1).

PMID: 39997616 PMC: 11858470. DOI: 10.3390/ncrna11010016.


Breakthrough Psoriasis in Patients Receiving Biologicals.

Damsin T, Absil G, Libon F, Tassoudji N, Nikkels A Psoriasis (Auckl). 2025; 15():1-8.

PMID: 39781106 PMC: 11705962. DOI: 10.2147/PTT.S502382.


Advanced whole transcriptome sequencing and artificial intelligence/machine learning (AI/ML) in imiquimod-induced psoriasis-like inflammation of human keratinocytes.

Wu L, Tsai S, Ho T, Chen H, Chiu Y, Peng Y Biomedicine (Taipei). 2025; 14(4):36-50.

PMID: 39777115 PMC: 11703395. DOI: 10.37796/2211-8039.1468.


MiR-128-3p promotes hyperproliferation of keratinocytes and psoriasis-like inflammation by targeting SIRT1/HIF-1α.

You J, Wang Z, Jia X Arch Dermatol Res. 2025; 317(1):165.

PMID: 39755881 DOI: 10.1007/s00403-024-03669-8.


References
1.
Shou Y, Yang L, Yang Y, Xu J . Inhibition of keratinocyte ferroptosis suppresses psoriatic inflammation. Cell Death Dis. 2021; 12(11):1009. PMC: 8551323. DOI: 10.1038/s41419-021-04284-5. View

2.
Zhang Y, Li Q, Rao E, Sun Y, Grossmann M, Morris R . Epidermal Fatty Acid binding protein promotes skin inflammation induced by high-fat diet. Immunity. 2015; 42(5):953-964. PMC: 4440244. DOI: 10.1016/j.immuni.2015.04.016. View

3.
Fry L, Baker B, Powles A, Fahlen A, Engstrand L . Is chronic plaque psoriasis triggered by microbiota in the skin?. Br J Dermatol. 2013; 169(1):47-52. DOI: 10.1111/bjd.12322. View

4.
Potgieter M, Bester J, Kell D, Pretorius E . The dormant blood microbiome in chronic, inflammatory diseases. FEMS Microbiol Rev. 2015; 39(4):567-91. PMC: 4487407. DOI: 10.1093/femsre/fuv013. View

5.
Taylor C, Burns D, Wiselka M . Extensive psoriasis induced by interferon alfa treatment for chronic hepatitis C. Postgrad Med J. 2000; 76(896):365-7. PMC: 1741616. DOI: 10.1136/pmj.76.896.365. View